Research Alliance Corp III quarterly report, Q2 FY2026

Business Context and Reporting Period

Company: Research Alliance Corporation III (RACC)
Reporting Period: Quarterly period ended June 30, 2026 (Inception: February 19, 2026)
Entity Type: Cayman Islands exempted company; Blank check company (SPAC); Emerging Growth Company; Smaller Reporting Company.
Business Status: The Company has not commenced operations. Activities are limited to formation, the Initial Public Offering (IPO), and identifying/negotiating a business combination. On July 26, 2026 (subsequent to the period end), the Company entered into a Business Combination Agreement with OHB Pediatrics Ltd. (OHBP).

Key Financial Metrics

Metric Value
Total Assets $76,307,137
Cash and Cash Equivalents $832,812
Marketable Securities (Trust Account) $75,238,468
Total Liabilities $2,305,587
Deferred Underwriting Fee $2,250,000
Working Capital $905,874
Net Income (3 Months Ended June 30, 2026) $54,050
Net Loss (Inception to June 30, 2026) $(11,199)
Interest Income (Trust Account) $238,468
Operating Expenses (3 Months) $184,418

Material Changes and Transactions

  • Initial Public Offering (IPO): Consummated on May 21, 2026. Sold 7,500,000 Class A ordinary shares at $10.00 per share, generating gross proceeds of $75,000,000. Offering costs totaled $3,762,251 (including $2,250,000 deferred underwriting commissions).
  • Private Placement: Simultaneously with the IPO, sold 275,000 Private Placement Shares to the Sponsor for $2,750,000.
  • Trust Account: $75,000,000 deposited into the Trust Account at IPO closing. As of June 30, 2026, the balance grew to $75,238,468 due to interest earned on U.S. government securities.
  • Repayment of Sponsor Note: Repaid a $300,000 promissory note from the Sponsor upon IPO closing.
  • Subsequent Event: Entered into a Business Combination Agreement with OHB Pediatrics Ltd. on July 26, 2026, including a $55,000,000 PIPE financing and a $75,000,000 backstop agreement.

Outlook, Risks, and Contingencies

  • Going Concern: The filing states that the Company lacks the financial resources to sustain operations for a reasonable period (one year) without completing a business combination or raising additional capital, raising substantial doubt about its ability to continue as a going concern.
  • Business Combination Timeline: The Company must complete a business combination within 24 months of the IPO (by May 2028) or liquidate. The proposed OHBP combination is expected to close in the second half of 2026.
  • Redemption Rights: Public shareholders have the right to redeem their shares for a pro rata portion of the Trust Account (approx. $10.00 per share plus interest) upon the completion of a business combination.
  • Internal Controls: Management identified a material weakness in internal control over financial reporting regarding the accounting for accounts payable and accrued expenses. A remediation plan is in progress.
  • Contingencies: The deferred underwriting fee of $2,250,000 is payable only upon the successful completion of a business combination. The Sponsor has agreed to indemnify the Trust Account against certain third-party claims.

Investor Verification Checklist

  • Business Combination Status: Verify the progress and closing conditions of the OHB Pediatrics Ltd. merger announced July 26, 2026.
  • Redemption Levels: Monitor shareholder redemption rates, which could impact the cash available for the transaction and the need for the $75,000,000 backstop.
  • Internal Control Remediation: Confirm the completion of the remediation plan for the material weakness in financial reporting controls.
  • Liquidity Sufficiency: Assess whether the $832,812 in working capital outside the Trust Account is sufficient to fund operations until the merger closes or liquidation occurs.
  • PIPE and Backstop Execution: Verify the finalization of the $55,000,000 PIPE financing and the terms of the backstop agreement.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.